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Residential pesticide use is widespread in the 
United States. Eighty-five percent of American 
households store at least one pesticide in their 
home, and approximately 10% of the mass of 
conventional pesticides used annually in the 
United States are applied in and around the 
home (Adgate et al. 2000; Kiely et al. 2004). 
Until its use was restricted, chlorpyrifos was 
one of the most widely used insecticides for 
residential pest control. Use was particularly 
heavy in New York City. During 1997, the 
amount of the insecticide applied by licensed 
applicators in New York City exceeded the 
amount applied in any other county in New 
York State, including agricultural commu-
nities (Thier 1998). In June 2000, the U.S. 
Environmental Protection Agency (EPA) 
entered into an agreement with the registrant 
to begin phasing out residential chlorpyrifos 
uses and to terminate all retail sales for indoor 
use by December 2001 (U.S. EPA 2000). 
Chlorpyrifos is still widely used in agricul-
ture, with approximately 10 million pounds 
applied annually in the United States; use 
on corn constitutes the largest market share 
(U.S. EPA 2002).
We have previously reported on chlor-
pyrifos concentrations in personal and indoor 
air samples among a cohort of 102 women 
residing in inner-city communities within New 
York City (Whyatt et al. 2007). Chlorpyrifos 
was detected in 99% of 48-hr maternal per-
sonal air samples during the 32nd week of 
pregnancy and in 99.7% of 2-week integrated 
indoor air samples collected sequentially from 
the 32nd week of pregnancy until delivery. 
There was little within-home variability in 
indoor air levels; between-home variability 
accounted for 92% of the variance in chlorpy-
rifos air concentrations. However, indoor and 
personal air samples declined significantly after 
the residential phaseout of chlorpyrifos use: 
from an average of 12.4 ng/m3 for indoor air 
and 9.3 ng/m3 for personal air among subjects 
monitored in 2001 to an average of 2.4 and 
2.2 ng/m3, respectively, among subjects moni-
tored in 2004. Here we report of a biomarker 
validation study within the same cohort.
Biological markers of chlorpyrifos have 
been used extensively in prior research to 
assess the extent and pathways of exposure in 
both children and adults (Clayton et al. 2003; 
Curl et al. 2002; Lu et al. 2006; Morgan et al. 
2005; Pang et al. 2002) and to evaluate the 
effects of exposure on fetal and postnatal 
development (Berkowitz et al. 2004; Engel 
et al. 2007; Eskenazi et al. 2004, 2007; Rauh 
et al. 2006; Whyatt et al. 2004). In general, 
biomonitoring studies of contemporary pes-
ticide exposures employ urine as the matrix 
because of ease of collection (Barr and Angerer 
2006). The most common urinary biomarker 
of chlorpyrifos is 3,5,6-trichloro-2-pyridinol 
(TCPy). TCPy is also a metabolite of chlo-
rpyrifos-methyl and triclopyr (Morgan et al. 
2005). Additionally, TCPy can be derived 
from exposure to environmental degradation 
products of chlorpyrifos (Barr and Angerer 
2006). Prior biomonitoring studies have also 
measured chlorpyrifos or its metabolite in 
blood and meconium (Whyatt and Barr 2001; 
Whyatt et al. 2003). However, no prior study 
has measured all of these biomarkers simul-
taneously within one cohort over a period 
when exposures were declining rapidly. The 
present biomarker validation study is nested 
within the longitudinal birth cohort study 
of 725 African-American and Dominican 
mothers and newborns from New York City 
being conducted by the Columbia Center for 
Children’s Environmental Health (CCCEH). 
It includes measurements of chlor  pyrifos or 
its metabolite in urine, blood, and meconium 
collected during pregnancy and after delivery 
from 102 mothers and newborns enrolled 
into the CCCEH cohort between 2001 and 
2004. The primary purpose of this study was 
to assess whether chlorpyrifos biomarkers 
declined after the phaseout of residential uses. 
We also undertook this study to evaluate the 
interrelationship between the biomarkers and 
to evaluate the within- and between-subject 
variability in TCPy levels in repeat spot urine 
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Ba c k g r o u n d: We previously documented significant decreases in chlorpyrifos concentrations 
in maternal personal and indoor air samples among pregnant African-American and Dominican 
women from New York City after the 2000–2001 restrictions on its residential use.
oB j e c t i v e: We undertook a biomarker validation study within the same cohort to evaluate trends 
over time in multiple biomarkers of prenatal chlorpyrifos exposure.
Me t h o d s : Subjects were enrolled between February 2001 and May 2004 (n = 102). We measured 
3,5,6-trichloro-2-pyridinol (TCPy) in postpartum meconium (n = 83), repeat prenatal maternal 
spot urine samples (n = 253), and postnatal urine from the mothers (n = 73) and newborns (n = 59). 
We measured chlorpyrifos in postnatal maternal (n = 92) and umbilical cord (n = 65) blood.
re s u l t s: We did not detect TCPy in infant urine, but all other biomarkers showed a highly sig-
nificant decrease in detection frequencies (χ2 = 7.8–34.0, p ≤ 0.005) and mean ranks (p ≤ 0.006, 
Kruskal–Wallis) among subjects enrolled in 2003–2004 compared with those enrolled in 2001–2002. 
Chlorpyrifos in maternal personal and indoor air declined 2- to 3-fold over the same period 
(p < 0.05). In 2001–2002 samples, TCPy levels in repeat prenatal urine were positively correlated 
(r = 0.23–0.56), but within-subject variability exceeded between-subject variability (intraclass cor-
relation coefficient = 0.43); indoor air levels explained 19% of the variance in prenatal urine TCPy 
(p = 0.001). Meconium TCPy concentrations were positively correlated with chlorpyrifos in maternal 
and cord blood (r = 0.25–0.33, p < 0.05) and with TCPy in maternal urine (r = 0.31, p < 0.01).
co n c l u s i o n s: Results suggest the biomarkers are reliable dosimeters to differentiate between 
groups with prenatal chlorpyrifos exposures varying by a factor of 2 or more and vividly illustrate 
the efficacy of residential restriction on chlorpyrifos to reduce the internal dose during pregnancy.
key w o r d s : biomarkers, chlorpyrifos, cord blood, indoor air, maternal blood, meconium, preg-
nancy, urine. Environ Health Perspect 117:559–567 (2009).  doi:10.1289/ehp.0800041 available 
via http://dx.doi.org/ [Online 5 December 2008]Whyatt et al.
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samples collected from the mothers during 
pregnancy. Chlorpyrifos has a short biological 
half-life in blood, adipose tissue, and urine of 
an estimated 24, 62, and 15–30 hr, respec-
tively (Barr and Angerer 2006). Previous 
research has documented significant intraindi-
vidual variability in urinary metabolite levels 
in children and adults (MacIntosh et al. 1999; 
Meeker et al. 2005), but no prior studies have 
assessed variability in TCPy levels in repeat 
spot urine samples collected from women 
during pregnancy.
Materials and Methods
The study includes 102 African-American 
and Dominican women selected from the 
CCCEH cohort. Enrollment criteria for the 
CCCEH cohort have been described else-
where (Perera et al. 2003; Whyatt et al. 2002, 
2003). Women were enrolled through the 
prenatal clinics at New York Presbyterian and 
Harlem Hospital Centers in New York City 
between 2001 and 2004. We restricted the 
study to women 18–35 years old who self-
identified as African American or Dominican 
and had resided in northern Manhattan 
(Central Harlem or Washington Heights/
Inwood) or the South Bronx for ≥ 1 year 
before pregnancy. Women were excluded if 
they smoked cigarettes or used other tobacco 
products during pregnancy, used illicit drugs, 
had diabetes, hypertension, or known HIV, 
or had their first prenatal visit after the 20th 
week of pregnancy. All women were regis-
tered to deliver at New York Presbyterian 
or Harlem Hospital Center. In addition to 
the enrollment criteria for the full CCCEH 
cohort, we restricted enrollment into the pres-
ent study to women who were not employed 
outside the home at the time of enrollment, 
to eliminate confounding from pesticide 
exposures in the workplace. Workplace expo-
sures would be difficult for the woman to reli-
ably quantify. We explained study procedures, 
including the personal and indoor air moni-
toring and collection of biological samples, to 
each subject at enrollment. We scheduled the 
personal and indoor air monitoring to com-
mence around the 32nd week of pregnancy. 
The study was approved by the Institutional 
Review Board at Columbia University, and all 
study subjects gave written informed consent 
before participating.
As described previously (Whyatt et al. 
2007), the women in the present study were 
comparable with women in the remaining 
CCCEH cohort in terms of maternal age, eth-
nicity, marital status, and annual household 
income, and a similar proportion reported 
using pest control methods during pregnancy. 
However, a greater proportion of women in 
the present study compared with those in 
the remaining CCCEH cohort reported less 
than a high school education (46% vs. 34%; 
χ2 = 5.8, p = 0.02), and a greater propor-
tion of the women in the remaining CCCEH 
cohort compared with those in the present 
study reported employment at some point 
during pregnancy (55.7% vs. 41%; χ2 = 7.4, 
p < 0.01). Most of the women (96%) in the 
present study lived in residential apartment 
buildings; the remaining lived in multifamily 
housing (n = 3) or in combined residential/
commercial buildings (n = 1).
Questionnaire data. We administered a 
45-min questionnaire to the women at the 
first home visit during the 32nd week of 
pregnancy. It included basic demographic 
information, neighborhood and home charac-
teristics, history of active and passive smoking, 
and history of exposures, including pesticide 
use during pregnancy. In addition, at each 
biweekly home visit, we administered a short 
10–15 min questionnaire to gather exposure 
information specific to pesticide exposures 
during the preceding 2 weeks. Questions 
included whether pests (specifically cock-
roaches, mice, rats, or other pests) were seen 
in the home, frequency of sightings over the 
2-week period, and whether any pest control 
measures were used over the prior 2 weeks 
either by an exterminator or by others in the 
home (the participant, building superinten-
dent, or other household member). If pest 
control measures were used, we gathered 
information on which methods were used, 
who used them, what pest they were used for, 
and how frequently they were used. Because 
47% of the cohort spoke Spanish, the inter-
views were conducted in both Spanish and 
English by a fully bilingual research staff. We 
gathered a total of 333 2-week questionnaires 
from the study participants; 74% of women 
completed three or more questionnaires.
Indoor and personal air sampling. The 
indoor air monitoring was conducted con-
tinuously beginning during the 32nd week of 
pregnancy until delivery. We collected 2-week 
integrated indoor air samples every 2 weeks 
throughout the monitoring period. We moni-
tored the air using a pump with a 0.5-L/min 
flow rate attached to a polyurethane foam 
(PUF) sampler with a 2.5-µm inlet cut fit-
ted with a 25-mm quartz fiber filter and a 
foam cartridge backup to capture semivolatile 
vapors and aerosols, as previously described 
(Whyatt et al. 2007). The pump was attached 
to a battery and operated at 0.5 L/min contin-
uously throughout the 2 weeks. Every other 
week, the PUF sampler was removed and a 
new sampler and battery attached. The indoor 
air monitoring continued until the woman 
went into labor, for an average of 7.0 ± 2.3 
(range, 1.9–12.4) weeks per home, with an 
average of 3.5 ± 1.1 (range, 1–6) 2-week inte-
grated indoor air samples collected per home. 
The monitoring continued for ≥ 6 weeks in 
80% of the homes. In four cases, we collected 
an additional 2-week integrated indoor air 
sample after delivery because predelivery sam-
ples had been lost through laboratory error. 
We collected the personal air sample from the 
mother over 48 hr during the 32nd week of 
pregnancy. We asked women in the cohort 
to wear a small backpack containing a per-
sonal ambient air monitor during the daytime 
hours for 2 consecutive days and to place the 
monitor near the bed at night. The personal 
air sampling pump operated continuously at 
4 L/min over this period, collecting particles 
of ≤ 2.5 µm in diameter on a quartz micro-
fiber filter and collecting semivolatile vapors 
and aerosols on a PUF cartridge backup. We 
collected a 48-hr personal air sample from 96 
of 102 (94%) of the women in the study. We 
initiated the indoor sampling at the conclu-
sion of the 48-hr personal air sampling.
We processed and analyzed indoor and 
personal air samples as described previously 
(Whyatt et al. 2007). Briefly, immediately 
after collection, the indoor and personal air 
monitoring samples were brought to the 
molecular epidemiologic laboratory at the 
Mailman School of Public Health, invento-
ried, and frozen. Once per month, air sam-
ples were shipped on dry ice to Southwest 
Research Institute and stored at –12°C. 
Within 10 days of arrival, the PUF plug 
and filter were placed in a Soxhlet extractor 
(Corning, Corning, NY), spiked with terphe-
nyl-d14 as a recovery, and extracted with 6% 
diethyl ether in hexanes for 16 hr. We then 
concentrated the extract to 1 mL and froze it 
at –12°C before analysis. We analyzed chlo-
rpyrifos by gas chromatography/mass spec-
trometry (GC/MS) as described previously 
(Whyatt et al. 2007).
Urine sample collection. We collected 
repeat prenatal maternal spot urine samples 
from women at the end of each 2-week indoor 
air sampling, beginning at the 34th week of 
pregnancy and continuing until delivery. We 
did not collect urine from women who went 
into labor before the end of the first 2 weeks 
of indoor air sampling. We collected a total of 
253 repeat prenatal spot urine samples from 
97 of 102 women (average of 2.6 samples 
per woman): 53 of 97 (53%) of the women 
provided three or more urine samples, 29 of 
97 (30%) two samples, and 15 of 97 (15%) 
provided one sample. We also collected a 
urine sample the day after delivery from 73 
women and 59 newborns. The prenatal urine 
collection took place in the woman’s home. 
The postnatal urine collection took place in 
the hospital. All maternal urine samples were 
collected using sterile cups supplied by the 
Centers for Disease Control and Prevention 
(CDC). Newborn urine samples were col-
lected using sterile newborn urine collection 
bags. Immediately after collection, the urine 
samples were transported to the laboratory, Prenatal chlorpyrifos biomarker
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inventoried, and frozen at –80°C before ship-
ment to CDC for analyses. Before freezing, a 
2-mL sample of urine was drawn off and fro-
zen separately for creatinine analysis.
Blood sample collection. A sample of 
umbilical cord blood was collected as soon 
after delivery as possible by drawing the blood 
into a heparinized syringe to avoid clotting. 
A sample of maternal blood was obtained 
within 2 days postpartum into heparinized 
Vacutainer tubes by the hospital staff. An 
umbilical cord blood sample was collected 
from 65 newborns, and a maternal blood 
sample was collected from 92 women; paired 
blood samples were available for 64 of the 
mothers and newborns. Within 12 hr of col-
lection, the cord and maternal blood samples 
were transferred to a centrifuge tube and spun 
for 15 min at 1,500 rpm. The plasma was col-
lected and stored at –80°C before shipment 
on dry ice to CDC.
Collection of postpartum meconium. 
Meconium samples were collected from 83 
newborns during the postpartum hospital 
stay. In 53 (64%) of the births, the meco-
nium samples were collected within 1 day of 
delivery; in 19 (23%) of the births, within 2 
days after delivery; and for 10 (12%) of the 
births, within 3 days after delivery; for one 
birth, the date of meconium collection was 
not recorded. The meconium was collected by 
transferring the sample from the diaper into a 
urine cup supplied by CDC. The sample was 
transported to the laboratory and stored at 
–80°C before shipment to CDC for pesticide 
analyses.
Analyses of pesticides and creatinine in 
biological samples. All biological samples were 
shipped on dry ice to CDC twice per year. 
Analysis of the pesticides or their metabolites 
in biological samples was conducted by the 
CDC using previously established methods 
(Barr et al. 2002; Olsson et al. 2004). Briefly, 
we spiked plasma samples (4 g) with stable 
isotopically labeled chlorpyrifos and mixed 
them well. We denatured the samples with 
saturated ammonium sulfate and extracted 
the super  natant using mixed-polarity solid-
phase extraction cartridges. We concentrated 
the eluate (in dichloromethane) and analyzed 
it using gas chromatography/high-resolution 
mass spectrometry at 10,000 resolving power 
(Barr et al. 2002) with both quantification 
and confirmation ions monitored. The urine 
samples (2 mL) were spiked with stable iso-
topically labeled TCPy, mixed well, and then 
subjected to an enzyme hydrolysis to liber-
ate glucuronide- and sulfate-bound TCPy. 
We extracted the hydrolysates using mixed-
polarity solid-phase extraction cartridges. The 
eluates (methanol) were concentrated and 
analyzed using HPLC/tandem MS (Olsson 
et al. 2004) with both quantification and con-
firmation ions monitored. We homogenized 
thawed meconium samples before analysis, 
because the pesticides may not be evenly dis-
tributed through the meconium. We extracted 
approximately 0.5–1 g of meconium with 
5 mL methanol. We concentrated the metha-
nol and then analyzed it using HPLC/tandem 
MS according to the analytical parameters of 
the modified method of Olsson et al. (2004). 
We quantified chlorpyrifos and TCPy, 
irrespective of matrix, using isotope dilution 
calibration. The limit of detection (LOD) of 
chlorpyrifos in blood samples was 0.5–1 pg/g 
plasma. The LOD of TCPy in urine samples 
was 0.26 ng/mL urine. The LOD for TCPy 
in meconium was 0.2 ng based on a sample 
weighing 0.5 g. Meconium samples analyzed 
in the present study weighed generally between 
0.5 and 0.7 g. Details on quality control and 
reproducibility for analyses of chlorpyrifos in 
blood and TCPy in urine have been published 
previously (Barr et al. 2002; Olsson et al. 2004). 
The relative standard deviation of TCPy in the 
meconium quality control pools was 16%.
We performed the urine creatinine mea-
surements according to the Roche Creatinine 
Plus Assay using a Roche Hitachi Automatic 
Analyzer model 912 (Roche Diagnostics, 
Indianapolis, IN). The Creatinine Plus 
Assay relies on the chemistry of creatinase 
and sarcosine oxidase. Through a series of 
chain reactions in which creatinine is con-
verted to creatine, which is in turn converted 
to sarcosine and urea, sarcosine is oxidized 
and hydrogen peroxide is formed. The per-
oxidase-catalyzed oxidation of a leuko dye 
by hydrogen peroxide produces a red color 
whose intensity is measured through absor-
bance readings and is directly proportional to 
the creatinine concentration in the sample.
Approximately 10% of all samples ana-
lyzed for chlorpyrifos, TCPy, or creatinine 
were positive or negative control samples. We 
used two concentrations of positive controls 
samples: one spiked at the mid-calibration 
range and one at the low calibration range. 
All positive control samples were evaluated 
according to the Westgard multirules of 
quality control (Westgard 2002) by an inde-
pendent quality assurance officer as well as 
laboratory personnel.
Statistical analyses. Descriptive analyses 
preceded formal hypothesis testing. We cal-
culated the percentage of biological samples 
with chlorpyrifos levels above the LOD. 
Before statistical analyses, pesticide values 
were log-transformed as needed to normalize 
their distributions. We assigned values below 
the LOD a value of half the LOD. We used 
nonparametric statistics if distributions could 
not be normalized after transformations. With 
nonparametric statistics, data are ranked and 
the statistical tests compare correlations or dif-
ferences in mean ranks between groups rather 
than differences in concentrations. Because no 
assumptions are made about the distribution 
of the data, nonparametric statistics are appro-
priate when a large proportion of the data are 
below the LOD (as was frequently the case 
in our study). When ranked values have the 
same numeric number (as is the case with 
values below the LOD), the rank is 0.5 times 
the number of ties. We used Spearman’s rank 
correlation coefficients to examine correlations 
between levels of chlorpyrifos or TCPy in the 
biological samples and to examine correlations 
between levels of chlorpyrifos or TCPy in 
the biological samples and chlorpyrifos levels 
in the indoor air samples. We used multiple 
linear regression to determine the amount 
of variance explained in prenatal maternal 
urine TCPy levels by the indoor air chlorpy-
rifos levels among subjects enrolled in 2001–
2002. We detected TCPy too infrequently 
to conduct analyses among subjects enrolled 
after 2002. We used analysis of variance or 
Kruskal–Wallis (depending on whether para-
metric or nonparametric analyses were appro-
priate) to test whether pesticide levels varied 
by year of monitoring (2001–2004) or among 
the following groups: women not using any 
pest control methods; women using nonspray 
methods only (sticky traps, bait traps, boric 
acid, and gels); and women using can sprays, 
pest bombs, or sprays by an exterminator, 
with or without nonspray methods. If lev-
els differed significantly among the groups, 
we used the least significant difference test 
or Mann–Whitney U-test to determine 
which groups varied significantly. We used 
group t-test or Mann–Whitney U-test to test 
whether pesticide levels differed significantly 
by ethnicity. We used chi-square analyses to 
test whether the frequencies of detection of 
chlorpyrifos to TCPy in the biological sam-
ples varied by year of the monitoring. We also 
used the chi-square test to compare detection 
frequencies of chlorpyrifos in maternal and 
cord blood samples. We used a mixed effects 
model to evaluate the within- and between-
subject variability in TCPy levels in the repeat 
maternal urine samples collected during preg-
nancy, and to calculate the intraclass correla-
tion coefficient (ICC). The ICC is a measure 
of reliability of repeated measures over time, 
defined as the ratio of between-subject vari-
ance to total variance. For these analyses we 
included women who had three repeat urine 
samples; we also restricted analyses to subjects 
enrolled in 2001–2002 because TCPy was 
detected in only one-third of samples among 
subjects enrolled after 2002 and the distribu-
tions could not be normalized.
Results were considered significant at 
p < 0.05. We performed analyses using SPSS 
(version 16.0; SPSS, Chicago, IL) except for 
the mixed effects models, for which we used 
PROC MIXED in SAS version 9.3 (SAS 
Institute Inc., Cary, NC).Whyatt et al.
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Results
Table 1 provides demographics for the cohort 
and gives the number of women who reported 
sighting of pests in the home or use of pest 
control measures between the 32nd week of 
pregnancy and delivery. Ninety (91%) of 
the women reported that they sighted pests; 
cockroaches were the pests sighted most fre-
quently. Fifty-nine (60%) of the women 
reported using some form of pest control 
during the study period: 31 women (32%) 
reported using baits, gels, and traps only, and 
28 (29%) reported using one or more of the 
spray methods (can sprays, sprays by exter-
minator, and pest bombs) with or without 
the other methods. There was no difference 
in self-reported pesticide use between African 
Americans and Dominicans. The women 
reported spending an average of 21.3 ± 1.75 
hr (range, 14–24 hr) per day at home between 
the 32nd week of pregnancy and delivery.
Table 2 provides levels of TCPy in repeat 
spot urine samples collected from the mother 
between the 34th week of pregnancy and deliv-
ery. We detected TCPy in one or more of the 
repeat prenatal urine samples collected from 62 
of 97 (64%) of the mothers. Mean TCPy con-
centration in prenatal urine was 1.4 ± 1.8 µg/g 
creatinine. We also detected TCPy in 42% of 
the postnatal urine sample (range, < LOD to 
8.7 µg/g creatinine). We did not detect TCPy 
in any of the urine samples collected from the 
newborns after delivery. Figure 1 shows detec-
tion frequencies and mean ranks of TCPy in 
the repeat prenatal urine samples by the year 
women enrolled into the study. Detection 
frequencies for TCPy dropped significantly 
between subjects enrolled in 2001–2002 and 
those enrolled in 2003–2004 for both prenatal 
(χ2 = 34.0, p < 0.001; Figure 1) and postnatal 
(χ2 = 20.3, p < 0.001; data not shown) mater-
nal urine samples. Mean ranks, adjusted for 
creatinine, also decreased significantly from 
65.2 in 2001 to 32.9 in 2004 for prenatal 
urine samples (p < 0.001; Figure 1) and from 
42.1 to 23.9 for postnatal urine (p < 0.001; 
data not shown). The difference in mean ranks 
for subjects enrolled in 2001–2002 compared 
with those enrolled in 2003–2004 was highly 
significant for both average maternal TCPy 
in urine during pregnancy (60.5 vs. 29.3; 
p < 0.001) and after delivery (42.1 vs. 23.9; 
p < 0.001). In addition, we found a signifi-
cant difference in mean ranks between subjects 
enrolled in 2001 and 2002 but no difference 
in mean ranks between subjects enrolled in 
2003 and 2004.
By comparison, among subjects enrolled 
in 2001–2002 compared with 2003–2004, 
chlorpyrifos levels in the 2-week integrated 
indoor air samples also decreased from 10.0 
to 3.2 ng/m3 (p = 0.002) and in mater-
nal 48-hr personal air samples from 8.1 to 
3.7 ng/m3 (p = 0.04; data not shown). TCPy 
levels in the repeat maternal urine samples 
during pregnancy were significantly higher 
among African-American  than  among 
Dominican women (mean ranks, 56.5 and 
41.9, respectively; Mann–Whitney U-test, 
p = 0.02). We found no difference in TCPy 
levels in maternal urine samples collected 
after delivery between African Americans 
and Dominicans, and no association between 
TCPy in maternal urine samples during preg-
nancy or after delivery and maternal self-
  reported pesticide use (data not shown).
Table 3 shows the correlation between 
the TCPy levels, adjusted for creatinine, in 
the repeat maternal urine samples collected 
during pregnancy and after delivery, both 
for all subjects and for subjects enrolled in 
2001–2002. The correlations were generally 
positive and often significant. Among women 
enrolled in 2001–2002, the ICC for TCPy 
in the repeat prenatal urine samples adjusted 
for creatinine was 0.43. Results were similar 
after adjusting for ethnicity. Among women 
enrolled after 2002, we detected TCPy too 
infrequently in urine samples to determine 
the ICC; however, we found no significant 
correlation between TCPy levels in the repeat 
urine samples (r-values ranged from –0.2 to 
0.2, p-values > 0.4; data not shown).
Table 4 shows the correlation between 
chlorpyrifos in the repeat 2-week integrated 
indoor air samples and TCPy levels in the 
repeat maternal spot urine samples collected 
over the same period. The correlations were 
positive and statistically significant in most 
cases. This was true both among all subjects 
Table 1. Cohort demographics and the number of women (%) reporting sightings of pests and use of pest 
control in the home over the final 2 months of pregnancy (n = 102).
Characteristica  No. (%)
Age [years (mean ± SE)]   25.2 ± 4.9
Ethnicity 
  African American  31 (31)
  Dominican  68 (68)
  Other  1 (1)
Marital status 
  Never married  69 (69)
  Marriedb  24 (24)
  Separated, widowed, divorced  7 (7)
Education 
  < High school degree   46 (46)
  High school diploma or GED  33 (33)
  Some college (< 4 years)  20 (20)
  College degree (4 years)  1 (1)
Income 
  < $10,000  36 (42.9)
  $10,000–$30,000  36 (42.9)
  > $30,000  12 (14.3)
Total number with pest sightings  90 (91)
  Sightings of cockroaches  79 (80)
  Sighting of rodents (mice and rats)  51 (51.5)
  Sightings of other pests  21 (21)
Total number using pest control  59 (60)
  Used sticky traps, gels, and baits only  31 (32)
  Used can sprays, pest bombs, or sprays by exterminator (with or without other methods)  28 (29)
GED, general educational diploma.
aMissing values: maternal age (n = 3), ethnicity (n = 2), marital status (n = 2), education (n = 2), income (n = 18), pest sight-
ings (n = 3), and pest control (n = 4). bIncludes women living as married with same partner > 7 years. 
Table 2. TCPy levels in repeat maternal spot urine samples between the 34th week of pregnancy and 
delivery and in a maternal urine sample after delivery, before adjusting for creatinine and after adjusting 
for creatinine.
  Percentile
Sample  No. > LOD/total (%)a  10th  25th  50th  75th  90th   95th
Before adjusting for creatinine (µg/L)         
  1st prenatal   49/95 (52)  < LOD  < LOD  0.46  2.1  3.7  7.8
  2nd prenatal   40/83 (48)  < LOD  < LOD  < LOD  1.3  2.6  3.5
  3rd prenatal   30/54 (56)  < LOD  < LOD  0.57  2.4  5.2  6.9
  4th prenatal   13/21 (62)  < LOD  < LOD  0.61  3.3  5.3  6.8
  Postnatal   29/73 (40)  < LOD  < LOD  < LOD  1.02  3.3  4.8
After adjustment for creatinine (µg/g creatinine)b
  1st prenatal   48/91 (53)  < LOD  < LOD  0.71  2.0  3.5  6.2
  2nd prenatal   40/83 (48)  < LOD  < LOD  < LOD  1.7   3.1  4.2
  3rd prenatal   30/53 (57)  < LOD  < LOD  0.83  2.1  5.2  6.4
  4th prenatal   13/19 (68)  < LOD  < LOD  1.3  4.3  5.8  6.8
  Postnatal   29/69 (42)  < LOD  < LOD  < LOD  1.5  2.9  4.5
aLOD = 0.26 µg/L. bCreatinine was missing for 11 urine samples.Prenatal chlorpyrifos biomarker
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and among subjects enrolled in 2001–2002. 
Among subjects enrolled in 2001–2002, aver-
age indoor air chlorpyrifos levels over the final 
2 months of pregnancy explained 19% of the 
variance in average TCPy levels in maternal 
repeat prenatal spot urine (p = 0.001). Results 
were similar after controlling for ethnicity. 
We found no association between chlorpy-
rifos in repeat indoor air samples and TCPy 
in the repeat maternal urine samples among 
subjects enrolled after 2002.
Table 5 provides detection frequencies and 
levels of chlorpyrifos in maternal and umbili-
cal cord blood and TCPy in meconium col-
lected from subjects after delivery. Figures 2 
and 3 show detection frequencies and mean 
ranks by year of enrollment. We detected 
TCPy in meconium more frequently and at 
higher levels than chlorpyrifos in the maternal 
or cord blood. Consistent with the trends 
we found with chlorpyrifos in the indoor 
and personal air samples and with TCPy in 
maternal urine samples, we found a highly 
significant difference in detection frequen-
cies and mean ranks by year of enrollment 
(Figures 2 and 3). The difference was seen 
only between subjects enrolled in 2003–2004 
and those enrolled in 2001–2002. We found 
no significant difference in biomarker lev-
els between subjects enrolled in 2001 com-
pared with 2002 or in 2003 compared with 
2004. However, between 2001–2002 and 
2003–2004, detection frequencies decreased 
significantly for TCPy in meconium (χ2 = 
22.1, p < 0.001) and chlorpyrifos in maternal 
blood (χ2 = 12.2, p < 0.001) and umbilical 
cord blood (χ2 = 7.8, p = 0.005). By 2003, 
TCPy was no longer detected in any meco-
nium and chlorpyrifos was not detected in 
any blood samples. Between 2001–2002 and 
2003–2004, mean ranks also decreased sig-
nificantly from 50.0 to below the LOD for 
TCPy in meconium (p < 0.001) and from 
51.7 and 36.4 to below LOD chlorpyrifos in 
maternal (p = 0.001) and umbilical cord blood 
(p = 0.006), respectively (Kruskal–Wallis).
Chlorpyrifos in blood and TCPy in meco-
nium were not associated with personal and 
indoor air chlorpyrifos levels, nor did they 
vary by maternal self-reported pesticide use 
or by ethnicity (data not shown). Further, we 
found no association between chlorpyrifos 
levels in maternal and cord blood and TCPy 
levels in maternal urine samples during preg-
nancy or after delivery. However, TCPy levels 
in meconium were weakly but significantly 
correlated with chlorpyrifos levels in mater-
nal (r = 0.25. p = 0.03) and umbilical cord 
(r = 0.33, p = 0.01) blood (Table 6) and with 
average TCPy levels in maternal urine samples 
during pregnancy (r = 0.31, p = 0.006) and 
after delivery (r = 0.32, p = 0.01; Table 6). 
Maternal and umbilical cord blood levels were 
highly correlated (r = 0.9, p < 0.001, n = 64). 
Of the 10 paired samples where the moth-
er’s levels were > LOD, the cord blood was 
> LOD in 8 of 10; of the 54 samples when 
the mother’s level was < LOD, the cord was 
also always < LOD (χ2 = 49.4, p < 0.001). 
When analyses were restricted to the 10 pairs 
where the mother’s levels were > LOD, the 
correlation between maternal and cord blood 
levels remained   statistically significant (r = 
0.71, p = 0.02).
Figure 1. Percentage of subjects with TCPy concentrations in one or more of repeat maternal prenatal 
urine samples > LOD (A) and mean TCPy ranks adjusted for creatinine (B) by year of sample collec-
tion. Sample size: 2001, n = 32; 2002, n = 25; 2003, n = 26; 2004, n = 14. (A) Chi-square, 2001–2002 versus 
2003–2004 = 34.0 (p < 0.001). (B) Mean ranks: 2001–2002 versus 2003–2004, 60.5 versus 29.3, p < 0.001, 
Kruskal–Wallis; 2001 versus 2002, p = 0.04; 2001 versus 2003, p < 0.001; 2001 versus 2004, p = 0.005; 2002 
versus 2003, p < 0.001; 2002 versus 2004, p = 0.01, Mann–Whitney U-test.
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Table 3. Spearman’s rank correlation of TCPy levels in repeat spot maternal urine samples during preg-
nancy and after delivery (µg/g creatinine) in all subjects and in subjects enrolled in 2001–2002. 
Sample  1st prenatal  2nd prenatal  3rd prenatal   4th prenatal
All subjects       
  Postpartum  0.25 (n = 61)  0.36** (n = 56)  0.25 (n = 39)  0.31 (n = 15)
  4th prenatal   0.49* (n = 18)  0.51* (n = 19)  0.29 (n = 19) 
  3rd prenatal   0.25 (n = 51)  0.69** (n = 52)   
  2nd prenatal  0.43** (n = 79)     
Subjects enrolled in 2001–2002   
  Postpartum  0.23 (n = 41)  0.18 (n = 40)  –0.18 (n = 29)  0.31 (n = 15)
  4th prenatal   0.49* (n = 18)  0.44 (n = 18)  0.23 (n = 18) 
  3rd prenatal   0.44** (n = 36)  0.43** (n = 36)   
  2nd prenatal  0.56** (n = 79)     
*p < 0.05, **p < 0.001.
Table 4. Spearman’s rank correlation between chlorpyrifos in 2-week integrated indoor air samples col-
lected between the 32nd–34th week of pregnancy through delivery and TCPy levels in spot maternal urine 
samples collected every 2 weeks over the same time period, among all subjects and among subjects 
enrolled in 2001–2002. 
  Metabolite levels in maternal urine samples (µg/g creatinine)
Indoor air (ng/m3)  1st prenatal  2nd prenatal  3rd prenatal   4th prenatal   Two-month average
All subjects (week of pregnancy)         
  32nd–34th  r = 0.38** (n = 85)       
  34th–36th    r = 0.28* (n = 76)     
  36th–38th      r = 0.33* (n = 47)   
  38th–40th         r = 0.45* (n = 19) 
  2-month average          r = 0.31* (n = 95)
Subjects enrolled 2001–2002 (week of pregnancy)     
  32nd–34th   r = 0.44** (n = 56)       
  34th–36th    r = 0.33* (n = 51)     
  36th–38th      r = 0.30 (n = 35)   
  38th–40th         r = 0.51* (n = 18) 
  2-month average          r = 0.44** (n = 57)
*p ≤ 0.05; **p ≤ 0.001.
Table 5. Chlorpyrifos levels in maternal and umbilical cord blood and TCPy levels in postpartum meconium 
collected after delivery.
  Percentile
Sample  No. > LOD/total (%)a  10th  25th  50th  75th  90th   95th
Maternal blood (pg/g)a  13/92 (14)  < LOD  < LOD  < LOD  < LOD  1.5  2.5
Umbilical cord blood (pg/g)a  8/65 (12)  < LOD  < LOD  < LOD  < LOD  2.3  2.5
Postpartum meconium (ng/g)b  23/83 (28)  < LOD  < LOD  < LOD  0.44  0.62  0.77
aLOD = 0.5–1 pg/g. bLOD = 0.2 ng.Whyatt et al.
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Discussion
The present study provided a unique oppor-
tunity to validate a battery of biomarkers of 
prenatal chlorpyrifos exposure, because we 
began the study after the phaseout of resi-
dential use of chlorpyrifos and during a time 
when exposure levels among the CCCEH 
cohort were decreasing rapidly (Whyatt et al. 
2007). Our prior research has shown that 
residential pesticide use is widespread among 
cohort women during pregnancy (Whyatt 
et al. 2005). Further, until use was restricted 
in 2001, chlorpyrifos was one of the most 
widely used insecticides for pest control in 
New York City (Thier 1998). However, after 
the restriction we documented a highly sig-
nificant decrease in chlorpyrifos levels in per-
sonal and indoor air levels from the women 
during pregnancy (Whyatt et al. 2007). In 
preliminary analyses, we also saw a significant 
decrease in chlorpyrifos levels in maternal and 
umbilical cord blood among subjects enrolled 
between 1999 and 2002 (Whyatt et al. 2005). 
We undertook the present study in a subset of 
102 mothers and newborns from the CCCEH 
cohort enrolled over a longer period. In addi-
tion to measuring chlorpyrifos in maternal 
and umbilical cord blood samples, we also 
measured levels of TCPy in repeat spot urine 
samples collected biweekly from the mother 
over the final 6–8 weeks of pregnancy, and 
in urine samples collected from both mother 
and newborn after delivery and TCPy in 
postpartum meconium. We did not detect 
TCPy in newborn urine. However, we saw 
a highly significant decrease in the detection 
frequency and mean ranks of all of the other 
biomarkers among subjects enrolled during 
years 2001–2004.
Both maternal and umbilical cord blood 
chlorpyrifos levels were below the LOD in all 
samples collected after 2002. We have pre-
viously reported that chlorpyrifos levels in 
umbilical cord blood among infants born in 
the cohort in 1999 averaged 6.9 pg/g and 
averaged 3.5 pg/g among those born in 2000 
(Whyatt et al. 2005). Here we report that 
we detected chlorpyrifos in only 19–29% of 
maternal and cord blood samples in 2001–
2002 but not in any blood samples collected 
in 2003–2004. Collectively, these results sug-
gest chlorpyrifos from residential use was the 
main contributor to the chlorpyrifos levels 
we have detected in both the maternal and 
umbilical cord blood among study subjects. 
Although it is likely that the women contin-
ued to receive some chlorpyrifos exposures 
after 2002, including exposure from the 
diet (Lu et al. 2006), any remaining levels 
were below the LOD of the blood measure-
ment. Consistent with our previous analy-
ses (Whyatt et al. 2004), maternal and cord 
chlor  pyrifos levels were highly correlated. It 
has been speculated that this correlation might 
have occurred because the amount of chlor-
pyrifos in maternal blood is in equilibrium 
with the amount in adipose tissue (Needham 
2005) and chlorpyrifos is readily transferred 
from maternal to cord blood across the pla-
cental (Whyatt et al. 2003). However, in our 
case the correlation was being driven prin-
cipally by the concordance of maternal and 
cord blood samples below the LOD.
We saw a similar and significant decrease 
in TCPy levels in meconium among subjects 
enrolled between years 2001 and 2004. As 
with the maternal and umbilical cord blood 
samples, levels of TCPy in meconium were 
above the LOD among infants born in 2001–
2002 but not in 2003–2004. However, before 
2003, TCPy was detected more frequently and 
at much higher levels in meconium than chlo-
rpyrifos in either maternal or umbilical cord 
blood samples. For example, among subjects 
Table 6. Spearman’s rank correlation of TCPy lev-
els in meconium and chlorpyrifos in maternal and 
umbilical cord blood and TCPy in spot urine sam-
ples collected from the mother during pregnancy 
and after delivery. 
Sample  TCPy levels in meconium (ng/g)
Chlorpyrifos in blood samples (pg/g) 
  Maternal blood   r = 0.25, p = 0.03, n = 79
  Umbilical cord blood   r = 0.33, p = 0.01, n = 56
TCPy in maternal urine (µg/g creatinine) 
  1st prenatal   r = 0.22, p = 0.06, n = 74
  2nd prenatal  r = 0.35, p = 0.003, n = 71
  3rd prenatal  r = 0.28, p = 0.06, n = 45
  4th prenatal  r = 0.40, p = 0.10, n = 17
  Average prenatal  r = 0.31, p = 0.006, n = 78
  After delivery  r = 0.32, p = 0.01, n = 60
Figure 2. Percentage of maternal and umbilical cord blood levels with chlorpyrifos concentrations 
> LOD (A) and mean chlorpyrifos ranks (B) by year of sample collection. Maternal blood sample size: 2001, 
n = 29; 2002, n = 22; 2003, n = 26; 2004, n = 15. Cord blood sample size: 2001, n = 21; 2002, n = 14; 2003, n = 20; 
2004, n = 10. (A) In maternal blood, 2001–2002 versus 2003–2004, χ2 = 12.2 (p < 0.001); in blood, 2001–2002 
versus 2003–2004, χ2 = 7.8 (p = 0.005). (B) Mean ranks, maternal blood: 2001–2002 versus 2003–2004, 51.7 
versus 40.0, p = 0.001, Kruskal–Wallis; 2001 versus 2003, p = 0.008; 2001 versus 2004, p = 0.04; 2002 versus 
2003, p = 0.005, Mann–Whitney U-test. Mean ranks, cord blood, 2001–2002 versus 2003–2004, 36.4 versus 
29.0, p = 0.006, Kruskal–Wallis; 2001 versus 2003, p = 0.04, Mann–Whitney U-test.
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Figure 3. Percentage of meconium samples with TCPy concentrations > LOD (A) and mean TCPy ranks (B) 
by year of sample collection. Sample size: 2001, n = 28; 2002, n = 21; 2003, n = 21; 2004, n = 13. (A) For sam-
ples > LOD, 2001–2002 versus 2003–2004, χ2 = 22.1, p < 0.001. (B) Mean ranks, 2001–2002 versus 2003–2004, 
50.0 versus 30.5, p < 0.001, Kruskal–Wallis; 2001 versus 2003, p < 0.001; 2001 versus 2004, p = 0.001; 2002 
versus 2003, p = 0.02, Mann–Whitney U-test.
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enrolled in 2001, 64% of meconium samples 
had detectable TCPy levels with a mean of 
0.43 ± 0.21 ng/g, whereas only 24% and 19% 
of maternal and umbilical cord blood samples 
had detectable levels of chlorpyrifos, with a 
range up to 3.0 pg/g. Further, TCPy levels 
in meconium were significantly correlated 
with chlorpyrifos levels in both maternal and 
umbilical cord blood and with TCPy levels 
in maternal urine samples, whereas we saw no 
association between chlorpyrifos in maternal 
and umbilical blood samples and TCPy in 
maternal urine samples. These results suggest 
that TCPy in meconium may provide a valid 
biomarker of prenatal exposure.
There has been considerable interest in 
the measurement of nonpersistent pesticides 
in meconium as a biomarker for exposures 
during pregnancy (Bearer 2003; Ostrea et al. 
2008; Wessels et al. 2003; Whyatt and Barr 
2001). In human fetuses, meconium begins to 
accumulate in the bowels at approximately 16 
weeks gestation and is generally not excreted 
until after delivery (Moriya et al. 1994). It 
has been hypothesized that xenobiotics enter 
the meconium as a consequence of bile excre-
tion into the intestines and/or of swallowing 
by the fetus of amniotic fluid (Ostrea 1999). 
Other mechanisms may be operating, as well 
(Mahone et al. 1994). Several lines of evi-
dence suggest that the half-life of xenobiotics 
in meconium may be protracted and meas-
ured levels can reflect exposures from the 
second trimester of pregnancy through deliv-
ery (Bearer et al. 1999, 2003). Most of the 
epidemiologic research to date has involved 
analysis of illicit drugs, alcohol, and tobacco 
products in meconium. Several studies sug-
gest that meconium measurements of these 
compounds are a more sensitive biomarker 
than maternal urine or cord bloods measure-
ments (Bearer et al. 2003; Browne et al. 1994; 
Dempsey et al. 1999; Konkol et al. 1994; 
Lewis et al. 1995; Maynard et al. 1991; Moore 
et al. 1998; Nair et al. 1994; Ostrea 1999; 
Ryan et al. 1994; Wingert et al. 1993) Dose–
response relationships have been detected 
between illicit drug use, cigarette smoking, 
and alcohol consumption during pregnancy 
and metabolite levels in meconium. Several 
studies have used concentrations of xeno-
biotics in meconium as a dosimeter to evalu-
ate effects of prenatal exposure on pregnancy 
outcome (Bearer et al. 2003; Delaney-Black 
et al. 1996; Mirochnick et al. 1995; Nuesslein 
et al. 1999; Ostrea 1999; Peterson et al. 2008; 
Tronick et al. 1996). For example, cotinine in 
meconium was significantly associated with 
infections of the lower respiratory tract dur-
ing the first 6 months, whereas no association 
was seen with self-reported parental tobacco 
consumption (Nuesslein et al. 1999). Fatty 
acid ethyl ester levels in meconium have been 
associated with maternal alcohol consumption 
during pregnancy (Bearer et al. 2003) and 
with adverse infant neurodevelopment post-
natally (Peterson et al. 2008). Although there 
have been relatively few studies of pesticides 
or their metabolites in meconium (Wessels 
et al. 2003), both organochlorines (Hong et al. 
2002; Zhao et al. 2007) and nonpersistent 
pesticides have been detected (Bielawski et al. 
2005; Ostrea et al. 2008; Whyatt and Barr 
2001). As was done here, most prior stud-
ies have collected meconium directly from 
the newborn diaper, which raises concerns 
about potential contamination of the meco-
nium by xenobiotics contained in infant urine. 
However, that does not appear to be the case 
in the present study because we did not detect 
TCPy in any of the paired newborn urine 
samples. To our knowledge, the present study 
is the first to show a correlation between levels 
of an organophosphate insecticide in meco-
nium and in other biological matrices collected 
during pregnancy. Additionally, this is the first 
study to reflect a decrease in insecticide levels 
in meconium after restrictions on residential 
use. These results suggest that meconium has 
promise as a biomarker for assessing effects 
of prenatal chlorpyrifos exposures on the 
developing fetus. This is encouraging, because 
meconium is a more readily accessible biologi-
cal matrix than umbilical cord blood, given 
that the latter has to be collected within min-
utes of delivery, whereas meconium is excreted 
over several days postpartum. Further, the 
fact that we saw a higher correlation between 
chlorpyrifos in maternal and cord blood than 
between chlorpyrifos in maternal and cord 
blood and TCPy in meconium does not neces-
sarily detract from the reliability of the meco-
nium biomarker, given that the time frames 
of exposure represented by the biomarkers 
are different (days in the case of the blood 
measures and potentially months in the case 
of meconium). However, additional valida-
tion research is clearly needed. It particular, no 
prior studies have evaluated the relationship 
between TCPy in meconium and postnatal 
outcomes. However, validation of biomarkers 
includes both the backward process of associ-
ating a biomarker with exposure and the for-
ward process of linking a biomarker with effect 
(Bearer 1998). In contrast, our prior research 
has shown significant associations between 
chlorpyrifos concentrations in umbilical cord 
blood, and newborn birth weight and length 
(Whyatt et al. 2004) and child mental and 
motor development at age 36 months (Rauh 
et al. 2006).
Because of ease of collection, prior biomon-
itoring studies of nonpersistent pesticides have 
generally collected urine samples rather than 
blood or meconium samples (Bradman and 
Whyatt 2005; Wessels et al. 2003). Most use 
spot urines rather than 24-hr or first morning 
void samples (Bradman and Whyatt 2005). 
However, a recent study measured TCPy and 
other nonpersistent pesticides in four urine 
samples collected from 13 children over 24 
hr in two different seasons and found levels 
measured in first morning void samples were 
the best predictor of weighted average daily 
metabolite concentrations (Kissel et al. 2005). 
Consistent with our findings, prior studies 
have documented significant intraindividual 
variability in TCPy levels in repeat spot urine 
samples collected from the same individual. 
A study by Meeker et al. (2005), for example, 
measured TCPy in nine repeat urine samples 
collected from 10 men over 3 months; ICCs 
ranged from 0.15 to 0.21 before and after 
adjustment for creatinine or specific gravity, 
indicating within-subject variability accounted 
for 79–85% of total variability. Another study 
that measured TCPy in up to six repeat urine 
samples collected over 1 year from 80 adults 
in Maryland showed that the average range of 
concentrations from the same individual was 
approximately 50% greater than the respec-
tive mean population levels (MacIntosh et al. 
1999). However, interindividual variability 
was found to be significantly greater than 
intra  individual variability in a study measuring 
TCPy levels in one to three first morning void 
urine samples collected from 102 children in 
Minnesota (Adgate et al. 2001). In the pres-
ent study, the ICC for TCPy in repeat urine 
samples from women enrolled in 2001–2002 
was 0.43, adjusting for creatinine; thus, 57% 
of total variability was explained by within-
subject variability. We detected TCPy too 
infrequently in urine samples among women 
enrolled after 2002 to calculate the ICC.
Despite the significant within-subject vari-
ability in urinary TCPy levels seen in the pres-
ent study, our ICCs were considerably higher 
than those seen in the Meeker et al. (2005) 
study described above. Before 2003, indoor 
air chlorpyrifos levels were a significant predic-
tor of TCPy in repeat maternal urine samples 
accounting for 19% of the variance in urinary 
TCPy. Because chlorpyrifos levels remained 
remarkably stable within most homes over 
this period, and between-home variability 
accounted for 92% of the variance in indoor 
air chlorpyrifos levels (Whyatt et al. 2007), the 
constant source of exposure may have reduced 
variability seen in urinary TCPy levels in this 
cohort relative to other cohorts. However, the 
low ICCs seen here coupled with those seen 
in prior studies do raise considerable concern 
over the reliability of TCPy in a single spot 
urine sample as a biomarker of exposure. It is 
also not known the extent to which TCPy in 
urine reflects exposure to chlorpyrifos or to 
TCPy itself in the environment (Bradman and 
Whyatt 2005; Morgan et al. 2005).
Nonetheless, our results suggest that all 
of the chlorpyrifos biomarkers assessed in 
the present study do provide reliable internal Whyatt et al.
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dosimeters to differentiate between groups 
having prenatal chlorpyrifos exposures vary-
ing by a factor of 2- to 3-fold. Specifically, 
we saw a highly significant difference in levels 
of all of the detected biomarkers (chlorpyri-
fos in blood samples and TCPy in maternal 
urine and meconium samples) among study 
subjects enrolled in 2001–2002 compared 
with those enrolled in 2003–2004. Between 
these two periods, chlorpyrifos in personal air 
samples declined approximately 2-fold, and 
chlorpyrifos in 2-week integrated indoor air 
samples declined approximately 3-fold. The 
biomarkers may also provide valid internal 
dosimeters to differentiate between groups 
having smaller exposure differentials, but our 
data do not permit us to assess this possibility. 
Our sample size in any year was small, expo-
sures were dropping rapidly and the principal 
difference in biomarker levels seen in the pres-
ent study was between subjects enrolled in 
2001–2002 and 2003–2004.
Limitations in this conclusion also need to 
be recognized. We have used the differential in 
chlorpyrifos in personal and indoor air sam-
ples as an estimate of the change in chlorpy-
rifos exposures among women in the cohort. 
However, we did not conduct an aggregate 
exposure assessment and so cannot directly 
test the accuracy of this estimate. Rather, we 
have based it partly on prior research indi-
cating that inhalation is a primary route of 
exposure to semivolatile insecticides after resi-
dential use (Pang et al. 2002; Whitmore et al. 
1994). Further, although dietary intakes can 
also be an important exposure route (Clayton 
et al. 2003; Morgan et al. 2005), we think 
it unlikely that dietary exposures changed 
appreciably over the course of the study. The 
U.S. EPA regulations were aimed principally 
at eliminating residential use of chlorpyri-
fos, and it is still widely used in agriculture 
including on food crops. In addition, we have 
based our assumption on the high correlations 
that have been seen in prior research between 
indoor and personal air levels of chlorpyrifos 
and other semivolatile insecticides and levels 
in carpet dust, hand wipes, and surfaces in 
the home (Gordon et al. 1999; Lewis 2004; 
Pang et al. 2002). A recent aggregate assess-
ment study of chlorpyrifos exposures among 
children also found a high correlation between 
exposures via the inhalation and dermal routes 
(Morgan et al. 2005). Thus, it is likely that 
the decrease in chlorpyrifos in personal and 
indoor air samples we found here also reflects 
a decrease in residential exposures via dermal 
absorption and nonintentional ingestion, but 
we did not measure the exact magnitude of 
the change in exposures via these other routes.
In conclusion, our prior research has shown 
that the U.S. EPA restrictions on residential 
uses of chlorpyrifos were remarkably effective at 
eliminating sales of the insecticide in inner-city 
communities in New York City (Carlton et al. 
2004) and at reducing personal and indoor 
air levels among subjects in the present cohort 
(Whyatt et al. 2007). The present study pro-
vides a vivid illustration of the efficacy of the 
restrictions to reduce the internal dose of chlor-
pyrifos to mother and fetus during pregnancy.
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